$6.96
0.14%
NYSE, Aug 08, 10:07 pm CET
ISIN
US87918A1051
Symbol
TDOC

Teladoc Inc Stock price

$6.96
-1.55 18.21% 1M
-6.90 49.78% 6M
-2.13 23.43% YTD
-0.25 3.47% 1Y
-31.83 82.06% 3Y
-186.78 96.41% 5Y
-23.51 77.16% 10Y
-21.54 75.58% 20Y
NYSE, Closing price Fri, Aug 08 2025
+0.01 0.14%

Key metrics

Basic
Market capitalization
$1.2b
Enterprise Value
$1.5b
Net debt
$313.5m
Cash
$679.6m
Shares outstanding
176.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.5 | 0.5
EV/Sales
0.6 | 0.6
EV/FCF
10.2
P/B
0.9
Financial Health
Equity Ratio
42.4%
Return on Equity
-67.2%
ROCE
-7.4%
ROIC
-8.0%
Debt/Equity
0.7
Financials (TTM | estimate)
Revenue
$2.5b | $2.6b
EBITDA
$176.5m | $280.7m
EBIT
$-183.5m | $-247.0m
Net Income
$-207.4m | $-202.0m
Free Cash Flow
$151.3m
Growth (TTM | estimate)
Revenue
-2.6% | -0.1%
EBITDA
2.8% | 70.4%
EBIT
14.5% | -18.3%
Net Income
79.4% | 79.8%
Free Cash Flow
-22.8%
Margin (TTM | estimate)
Gross
70.3%
EBITDA
6.9% | 10.9%
EBIT
-7.2%
Net
-8.2% | -7.9%
Free Cash Flow
6.0%
More
EPS
$-1.2
FCF per Share
$0.9
Short interest
15.6%
Employees
5k
Rev per Employee
$510.0k
Show more

Is Teladoc Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Teladoc Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

33 Analysts have issued a Teladoc Inc forecast:

10x Buy
30%
23x Hold
70%

Analyst Opinions

33 Analysts have issued a Teladoc Inc forecast:

Buy
30%
Hold
70%

Financial data from Teladoc Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,542 2,542
3% 3%
100%
- Direct Costs 756 756
1% 1%
30%
1,786 1,786
3% 3%
70%
- Selling and Administrative Expenses 1,322 1,322
2% 2%
52%
- Research and Development Expense 288 288
13% 13%
11%
176 176
3% 3%
7%
- Depreciation and Amortization 360 360
7% 7%
14%
EBIT (Operating Income) EBIT -183 -183
15% 15%
-7%
Net Profit -207 -207
79% 79%
-8%

In millions USD.

Don't miss a Thing! We will send you all news about Teladoc Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Teladoc Inc Stock News

Positive
The Motley Fool
11 days ago
Teladoc (TDOC) Q2 Revenue Tops Estimates
Positive
Seeking Alpha
12 days ago
Teladoc Health remains a deep value play at $7, trading at just 5-6x EBITDA, but lacks a clear growth catalyst. Revenue and user metrics are declining across core segments, with BetterHelp and Chronic Care both losing momentum and failing to innovate. Recent acquisitions (UpLift, Catapult Health) have not meaningfully expanded Teladoc's platform or addressed its reliance on basic telehealth con...
Positive
Seeking Alpha
12 days ago
Teladoc's Q2 2025 earnings reaffirm strong free cash flow guidance, with the potential to reach $220 million in the next twelve months. Despite an attractive 7x next year's free cash flow valuation, revenue growth remains stagnant and threatens the bull case. Profitability and an improving balance sheet keep me tepidly bullish, but lack of growth and competitive pressures are major risks.
More Teladoc Inc News

Company Profile

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002 by George Byron Brooks and is headquartered in Purchase, NY.

Head office United States
CEO Charles Divita
Employees 5,060
Founded 2002
Website www.teladochealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today